65 results
6-K
EX-99.2
AUTL
Autolus Therapeutics plc
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
with the research and development of our product candidates, which are partially offset by U.K. research and development expenditure tax credits provided by His … Program).
Un-surrendered U.K. losses may be carried forward indefinitely to be offset against future taxable profits, subject to numerous utilization
6-K
EX-99.2
AUTL
Autolus Therapeutics plc
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm
in connection with the research and development of our product candidates, which are partially offset by U.K. research and development expenditure tax … the RDEC regime to the extent that our projects are grant funded.
Un-surrendered U.K. losses may be carried forward indefinitely to be offset against
6-K
EX-99.2
AUTL
Autolus Therapeutics plc
6 May 21
Index to Condensed Consolidated Financial Statements
4:05pm
expenses consist of costs incurred in connection with the research and development of our product candidates, which are partially offset by U.K. research … to be offset against future taxable profits, subject to numerous utilization criteria and restrictions. The amount that can be offset each year
6-K
EX-99.2
AUTL
Autolus Therapeutics plc
5 May 22
Index to Condensed Consolidated Financial Statements
12:00am
and development of our product candidates, which are partially offset by U.K. research and development expenditure tax credits provided by Her Majesty’s … indefinitely to be offset against future taxable profits, subject to numerous utilization criteria and restrictions. The amount that can be offset each year
6-K
EX-99.2
AUTL
Autolus Therapeutics plc
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
and development expenses consist of costs incurred in connection with the research and development of our product candidates, which are partially offset by U.K … U.K. losses may be carried forward indefinitely to be offset against future taxable profits, subject to numerous utilization criteria and restrictions
6-K
EX-99.2
onttb
3 Nov 21
Index to Condensed Consolidated Financial Statements
4:05pm
6-K
EX-99.2
oeuh0cz29cm6
5 Aug 21
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-99.2
dbm7zc221478
8 Aug 19
Index to Condensed Consolidated Financial Statements
4:36pm
6-K
EX-99.2
m93g33uwu4i
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-99.2
e1220b aooiuu2ab
6 Aug 20
Current report (foreign)
4:06pm
6-K/A
EX-99.2
djpf7qu u53bpnu
21 Nov 22
Current report (foreign) (amended)
4:03pm
6-K
EX-99.2
8f3 kz6f8g
5 Nov 20
Index to Condensed Consolidated Financial Statements
4:03pm
6-K
EX-99.2
rav6j5nk02xvmkc4i
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.2
218r4pj3wy0ete
7 Nov 19
Index to Condensed Consolidated Financial Statements
4:28pm
6-K
EX-99.2
xjficdoo
7 May 20
Index to Condensed Consolidated Financial Statements
12:00am
10-Q
g17 moupu
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.2
lqlkkeynxf 6ggsv7
14 May 19
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.3
u62u9s
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.3
owlg56a5pij6
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm